OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Pharmacology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Issue Information	469
	330
Issue Information	254
	251
Issue Information	178
Graph‐based algorithms to dissect long‐distance water‐mediated H‐bond networks for conformational couplings in GPCRs	163
Correction to “Melatonin epigenetic potential on testicular functions and fertility profile in varicocele rat model is mediated by silent information regulator 1”	157
Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice	156
	146
Role of Na_V1.7 in action potential conduction along human bronchial vagal afferent C‐fibres	146
Gβγ subunit signalling underlies neuropeptide Y‐stimulated vasoconstriction in rat mesenteric and coronary arteries	139
	127
Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice	123
Exploring pharmacological inhibition of G_q/11 as an analgesic strategy	120
The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine	93
Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review	93
Chemosensory signalling in human sperm is controlled by Ca²⁺ influx via CatSper and Ca²⁺ clearance via plasma membrane Ca²⁺ ATPases	91
Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning	89
EXPRESSION OF CONCERN: Nitropravastatin Stimulates Reparative Neovascularisation and Improves Recovery from Limb Ischaemia in Type‐1 Diabetic Mice	83
Structural and molecular determinants of mineralocorticoid receptor signalling	81
GPR84 in physiology—Many functions in many tissues	71
Dual action of macrophage miR‐204 confines cyclosporine A‐induced atherosclerosis	68
P2X2 receptor subunit interfaces are missense variant hotspots, where mutations tend to increase apparent ATP affinity	67
Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin	66
The potential for biased signalling in the P2Y receptor family of GPCRs	65

Palbociclib blocks neutrophilic phosphatidylinositol 3‐kinase activity to alleviate psoriasiform dermatitis	64
A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR	60
Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABA_A receptors	59
Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction	57
Opportunities of patient‐derived organoids in drug development	55
The fast‐dissociating D₂ antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment	54
Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer	54
Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury	51
Allosterism in the adenosine A_2A and cannabinoid CB₂ heteromer	50
Supersulfide biology and translational medicine for disease control	50
A new class of 5‐HT_2A/5‐HT_2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins	49
Novel therapeutic approaches to target neurodegeneration	48
Issue Information	48
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline	48
Development of new K_ir2.1 channel openers from propafenone analogues	46
Insight in article retractions inBritish Journal of Pharmacologybetween the years 2000–2023. Implications for reducing fraud‐containing articles	45
The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial	43
Silibinin, a commonly used therapeutic agent for non‐alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19	43